Skip to main content
< Back
About
About the conference
Organisers & Partners
Registration
App
Podcast
Early Career Researchers
Call for abstracts
Guidelines
Latest updates
Press room
Venue
Programme
Full programme
Programme outline
Tracks
Speakers
All speakers
Keynote speakers
Side events
Subscribe
Programme
Keywords
Africa
Alcohol
Asia
Basic research
Behavioural addictions
Cannabis
Capacity-building
Civil society
Clinical research/practice
Comorbidity
COVID-19
Criminal justice/prisons
Criminology
Drug user's perspectives
E-health/digitalisation
ECR (Early Career Researchers)
Europe
Gender perspectives
Harm reduction
Health inequalities
Hepatitis
HIV
Infectious diseases
Markets
Mental health and wellbeing
Monitoring and evaluation
Neuroscience
New psychoactive substances
Nicotine/tobacco
North America
Oceania
Opiates
Overdose
Policy
Prescription drugs
Prevention
Psychostimulants
Public health
Qualitative methods
Quantitative methods
Recreational setting
Risky behaviours
South America
Toxicology and forensic analysis
Treatment
Underrepresented groups
Workforce
Youth/children
- Any -
WED
23 OCT
THU
24 OCT
FRI
25 OCT
All
Plenary session
Big debate
Major session
Workshop
Oral presentation session
Short communication session
e-short communication session
e-poster session
Video contest
PDF version
Wed 23 Oct
10:00
e-poster session day 1
10:00
to
19:20
Digital kiosks
e-poster session
11:50
Advances in drug treatment
11:50
to
13:20
Auditorium II
Oral presentation session
Innovative health approaches
11:50
to
13:20
Auditorium III
Oral presentation session
Advancing addiction research: global perspectives and collaborative initiatives
11:50
to
13:20
Auditorium VI
Oral presentation session
Lives at risk: mental health and substance use
11:50
to
13:20
Auditorium VII
Oral presentation session
Prevalence of opioids and related harms
11:50
to
13:20
Auditorium VIII
Oral presentation session
Building addiction workforce capacity
11:50
to
13:20
Room 5C
Oral presentation session
Treatment of alcohol use disorder
11:50
to
13:20
Room 1.05
Short communication session
Support for recovery
11:50
to
13:20
Room 1.07
Short communication session
14:20
Neuroscience and cognition
14:20
to
15:50
Auditorium III
Short communication session
Tobacco, mental health and other substance use
14:20
to
15:50
Auditorium VII
Oral presentation session
Alcohol use disorder: clinical biology and epidemiology
14:20
to
15:50
Room 1.05
Short communication session
Meetings the needs of women who use drugs or alcohol
14:20
to
15:50
Room 1.06
Short communication session
Methods and measurement
14:20
to
15:50
Room 1.08
Short communication session
16:00
Alcohol use from brief intervention to harm reduction
16:00
to
17:30
Auditorium II
Oral presentation session
The recovery journey
16:00
to
17:30
Auditorium III
Oral presentation session
Substance use and psychosis
16:00
to
17:30
Auditorium VII
Oral presentation session
Surveillance of drug-related morbidity and mortality
16:00
to
17:30
Room 5A
Oral presentation session
Inequalities and needs of migrant groups
16:00
to
17:30
Room 5C
Oral presentation session
Responses to behavioural addictions
16:00
to
17:30
Room 1.05
Short communication session
Quality in addictions work systems
16:00
to
17:30
Room 1.06
Oral presentation session
Conceptualising health and harms
16:00
to
17:30
Room 1.08
Short communication session
Trauma and addiction - developing skills in the screening of traumatic experiences in addiction care
16:00
to
17:30
Room 1.10
Workshop
17:50
The EUFAS-EAR European Addiction Research Award
17:50
to
19:20
Auditorium I
Major session
Decriminalisation and alternatives to arrest
17:50
to
19:20
Auditorium VI
Oral presentation session
Psychedelics 1
17:50
to
19:20
Auditorium VIII
Oral presentation session
Novel and contextual approaches in prevention
17:50
to
19:20
Room 5A
Oral presentation session
Opioid treatment 1
17:50
to
19:20
Room 5B
Oral presentation session
Hepatitis C, HIV, and other drug related harms
17:50
to
19:20
Room 1.05
Short communication session
Opioids: trends, use and treatments
17:50
to
19:20
Room 1.06
Short communication session
Thu 24 Oct
11:50
International collaboration to understand and address the co-occurrence of addiction with ADHD and autism spectrum disorders
11:50
to
13:20
Auditorium I
Major session
Predicting the future: biomarkers for progression of alcohol use disorder
11:50
to
13:20
Auditorium II
Oral presentation session
Opioid treatment 2
11:50
to
13:20
Auditorium III
Oral presentation session
Opioid Agonist Treatment: novel formulations and challenges
11:50
to
13:20
Auditorium IV
Oral presentation session
Workers reaching marginalised groups
11:50
to
13:20
Room 5C
Oral presentation session
Contemporary issues
11:50
to
13:20
Room 1.08
Oral presentation session
Back-casting exercise on peer-support workforce development
11:50
to
13:20
Room 1.15
Workshop
14:20
New opportunities for informing clinical practice and policy development in the area of behavioural addictions
14:20
to
15:50
Auditorium I
Major session
Understanding drug-related deaths
14:20
to
15:50
Auditorium IV
Oral presentation session
Pregnancy, drug use and care
14:20
to
15:50
Room 5B
Oral presentation session
Co-creating robust systems with workers
14:20
to
15:50
Room 5C
Oral presentation session
Understanding harm reduction: economic, social, and health perspectives
14:20
to
15:50
Room 1.05
Short communication session
Women's realities of drug use
14:20
to
15:50
Room 1.08
Oral presentation session
16:00
How can treatment be a better experience?
16:00
to
17:30
Auditorium VII
Oral presentation session
A unique care model for inpatient addictions and tri-morbidity within an acute UK hospital
16:00
to
17:30
Room 5C
Oral presentation session
17:50
Alcohol and gender issues
17:50
to
19:20
Auditorium II
Oral presentation session
Mixed methods for understanding drug use
17:50
to
19:20
Auditorium III
Oral presentation session
Viral hepatitis among people who inject drugs
17:50
to
19:20
Auditorium IV
Oral presentation session
Alcohol use among the elderly
17:50
to
19:20
Auditorium VI
Oral presentation session
Substance use and mental health in treatment settings
17:50
to
19:20
Auditorium VII
Oral presentation session
Newly Regulated Markets, Managing Harms, Treatment & Advocating for Reform
17:50
to
19:20
Room 1.06
Short communication session
ScaleUp: Options for scalable psychosocial and pharmacological treatment of stimulant use disorder
17:50
to
19:20
Room 1.08
Oral presentation session
Fri 25 Oct
11:50
Alcohol: interventions and up-to-date technologies
11:50
to
13:20
Auditorium II
Oral presentation session
Psychedelics 2
11:50
to
13:20
Auditorium VI
Oral presentation session
Trauma and substance use
11:50
to
13:20
Auditorium VII
Oral presentation session
Online monitoring
11:50
to
13:20
Room 5B
Oral presentation session
Substance use and treatment needs across European prisons
11:50
to
13:20
Room 5C
Oral presentation session
Emerging challenges in drug markets: monitoring, measurement & impacts
11:50
to
13:20
Room 1.05
Short communication session
Intimate partner violence perpetration: The ADVANCE-Digital Programme for men
11:50
to
13:20
Room 1.15
Workshop
14:20
Alcohol and other drug policies in the work setting – a perspective on European developments
14:20
to
15:50
Auditorium II
Oral presentation session
Addressing diverse treatment needs
14:20
to
15:50
Auditorium VI
Oral presentation session
Regulating cannabis supply policies in Europe: navigating the long road to change
14:20
to
15:50
Auditorium VIII
Oral presentation session
Holistic care for mental well-being
14:20
to
15:50
Room 1.05
Short communication session
MENU
Back
EUROPE POC
My profile
Notifications
My favourites
Scan contacts
My contacts
Settings